190 related articles for article (PubMed ID: 22646997)
1. Nanosized multifunctional polyplexes for receptor-mediated siRNA delivery.
Dohmen C; Edinger D; Fröhlich T; Schreiner L; Lächelt U; Troiber C; Rädler J; Hadwiger P; Vornlocher HP; Wagner E
ACS Nano; 2012 Jun; 6(6):5198-208. PubMed ID: 22646997
[TBL] [Abstract][Full Text] [Related]
2. Dual antitumoral potency of EG5 siRNA nanoplexes armed with cytotoxic bifunctional glutamyl-methotrexate targeting ligand.
Lee DJ; Kessel E; Edinger D; He D; Klein PM; Voith von Voithenberg L; Lamb DC; Lächelt U; Lehto T; Wagner E
Biomaterials; 2016 Jan; 77():98-110. PubMed ID: 26584350
[TBL] [Abstract][Full Text] [Related]
3. Polycation-detachable nanoparticles self-assembled from mPEG-PCL-g-SS-PDMAEMA for in vitro and in vivo siRNA delivery.
Lin D; Jiang Q; Cheng Q; Huang Y; Huang P; Han S; Guo S; Liang Z; Dong A
Acta Biomater; 2013 Aug; 9(8):7746-57. PubMed ID: 23624221
[TBL] [Abstract][Full Text] [Related]
4. Single-step assembly of cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNA.
Yang XZ; Dou S; Wang YC; Long HY; Xiong MH; Mao CQ; Yao YD; Wang J
ACS Nano; 2012 Jun; 6(6):4955-65. PubMed ID: 22646867
[TBL] [Abstract][Full Text] [Related]
5. Targeted polymeric micelles for siRNA treatment of experimental cancer by intravenous injection.
Christie RJ; Matsumoto Y; Miyata K; Nomoto T; Fukushima S; Osada K; Halnaut J; Pittella F; Kim HJ; Nishiyama N; Kataoka K
ACS Nano; 2012 Jun; 6(6):5174-89. PubMed ID: 22575090
[TBL] [Abstract][Full Text] [Related]
6. Post-PEGylation of siRNA Lipo-oligoamino Amide Polyplexes Using Tetra-glutamylated Folic Acid as Ligand for Receptor-Targeted Delivery.
Müller K; Kessel E; Klein PM; Höhn M; Wagner E
Mol Pharm; 2016 Jul; 13(7):2332-45. PubMed ID: 27177200
[TBL] [Abstract][Full Text] [Related]
7. Tumoral gene silencing by receptor-targeted combinatorial siRNA polyplexes.
Lee DJ; He D; Kessel E; Padari K; Kempter S; Lächelt U; Rädler JO; Pooga M; Wagner E
J Control Release; 2016 Dec; 244(Pt B):280-291. PubMed ID: 27287890
[TBL] [Abstract][Full Text] [Related]
8. A mesoporous silica nanoparticle--PEI--fusogenic peptide system for siRNA delivery in cancer therapy.
Li X; Chen Y; Wang M; Ma Y; Xia W; Gu H
Biomaterials; 2013 Jan; 34(4):1391-401. PubMed ID: 23164421
[TBL] [Abstract][Full Text] [Related]
9. Smart multilayered assembly for biocompatible siRNA delivery featuring dissolvable silica, endosome-disrupting polycation, and detachable PEG.
Suma T; Miyata K; Anraku Y; Watanabe S; Christie RJ; Takemoto H; Shioyama M; Gouda N; Ishii T; Nishiyama N; Kataoka K
ACS Nano; 2012 Aug; 6(8):6693-705. PubMed ID: 22835034
[TBL] [Abstract][Full Text] [Related]
10. Native chemical ligation for conversion of sequence-defined oligomers into targeted pDNA and siRNA carriers.
Zhang CY; Kos P; Müller K; Schrimpf W; Troiber C; Lächelt U; Scholz C; Lamb DC; Wagner E
J Control Release; 2014 Apr; 180():42-50. PubMed ID: 24566255
[TBL] [Abstract][Full Text] [Related]
11. Enhanced siRNA delivery and silencing gold-chitosan nanosystem with surface charge-reversal polymer assembly and good biocompatibility.
Han L; Zhao J; Zhang X; Cao W; Hu X; Zou G; Duan X; Liang XJ
ACS Nano; 2012 Aug; 6(8):7340-51. PubMed ID: 22838646
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of a bioresponsive and endosomolytic siRNA-polymer conjugate.
Meyer M; Dohmen C; Philipp A; Kiener D; Maiwald G; Scheu C; Ogris M; Wagner E
Mol Pharm; 2009; 6(3):752-62. PubMed ID: 19348503
[TBL] [Abstract][Full Text] [Related]
13. Targeted decationized polyplexes for siRNA delivery.
Novo L; Takeda KM; Petteta T; Dakwar GR; van den Dikkenberg JB; Remaut K; Braeckmans K; van Nostrum CF; Mastrobattista E; Hennink WE
Mol Pharm; 2015 Jan; 12(1):150-61. PubMed ID: 25384057
[TBL] [Abstract][Full Text] [Related]
14. In vivo delivery of small interfering RNA to tumors and their vasculature by novel dendritic nanocarriers.
Ofek P; Fischer W; Calderón M; Haag R; Satchi-Fainaro R
FASEB J; 2010 Sep; 24(9):3122-34. PubMed ID: 20385622
[TBL] [Abstract][Full Text] [Related]
15. Design of multifunctional gold nanoparticles for in vitro and in vivo gene silencing.
Conde J; Ambrosone A; Sanz V; Hernandez Y; Marchesano V; Tian F; Child H; Berry CC; Ibarra MR; Baptista PV; Tortiglione C; de la Fuente JM
ACS Nano; 2012 Sep; 6(9):8316-24. PubMed ID: 22882598
[TBL] [Abstract][Full Text] [Related]
16. Development of poly(amino ester glycol urethane)/siRNA polyplexes for gene silencing.
Tseng SJ; Tang SC
Bioconjug Chem; 2007; 18(5):1383-90. PubMed ID: 17567100
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer cell-specific VEGF siRNA delivery system using cell targeting peptide conjugated polyplexes.
Kim SH; Lee SH; Tian H; Chen X; Park TG
J Drug Target; 2009 May; 17(4):311-7. PubMed ID: 19242850
[TBL] [Abstract][Full Text] [Related]
18. Histidine-rich stabilized polyplexes for cMet-directed tumor-targeted gene transfer.
Kos P; Lächelt U; Herrmann A; Mickler FM; Döblinger M; He D; Krhač Levačić A; Morys S; Bräuchle C; Wagner E
Nanoscale; 2015 Mar; 7(12):5350-62. PubMed ID: 25721131
[TBL] [Abstract][Full Text] [Related]
19. Targeted delivery of small interfering RNA to angiogenic endothelial cells with liposome-polycation-DNA particles.
Vader P; Crielaard BJ; van Dommelen SM; van der Meel R; Storm G; Schiffelers RM
J Control Release; 2012 Jun; 160(2):211-6. PubMed ID: 21983283
[TBL] [Abstract][Full Text] [Related]
20. Factors influencing polycation/siRNA colloidal stability toward aerosol lung delivery.
Steele TW; Zhao X; Tarcha P; Kissel T
Eur J Pharm Biopharm; 2012 Jan; 80(1):14-24. PubMed ID: 21924355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
